Table 1. Clinical data of the patients.

	N = 45
Gender, male/female	20/25
Median age, years	29 (10–62)
WBC, ×109/L
Median	2.3 (0.2–47.5)
<10	1.9 (0.2–7.8, 84.4%)
≥10	37.9 (13.2–47.5, 15.6%)
Median Hb, g/L	81.0 (38.0–120.0)
Median platelet, ×109/L	23.0 (5.0–120.0)
Clinical CR	95.6%
Median days to clinical CR	30 (20–60)
Median months to molecular CR	6 (2–12)